Status:
COMPLETED
Epiretinal Fibrosis, Effect of Early Surgery
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Epiretinal Membrane
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized clinical trial is to investigate when it is optimal to treat the eye disease epiretinal fibrosis. Hypothesis: In a population of patients with symptomatic idiopathic epire...
Detailed Description
Epiretinal fibrosis is a disease of the macula, which affects the central retina, and there by the central vision. Epiretinal fibrosis is due to a growth of connective tissue on retinas surface. From...
Eligibility Criteria
Inclusion
- Subjective loss of visual acuity and/or visual distortions
- Visual acuity more than or equal to 35 ETDRS letters (at 4 meter)
- Duration of symptoms Less than 13 months
- Metamorphopsia on a Amsler Grid
- Binocular vision disturbed
Exclusion
- Diabetic eye symptoms
- Previous oculary surgery, except cataract
- Presence of hard drusen in age-related macular degeneration (AMD)
- Other serious eye diseases
- Patients unable to complete the follow up
- not legal guardian of themselves
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00902629
Start Date
May 1 2008
End Date
February 1 2015
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye department, Glostrup University hospital
Glostrup Municipality, Copenhagen, Denmark, 2600